Canine ocular histiocytic sarcoma

Veterinary Ophthalmology

Volumn 10, Issue 3, 2007, Pages 179-185

  Naranjo, Carolina ^a   Dubielzig, Richard R ^b   Friedrichs, Kristen R ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Canine; CD18; Histiocytic sarcoma; Immunohistochemistry

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EYE TUMOR; FACTUAL DATABASE; FEMALE; HISTIOCYTIC LYMPHOMA; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; UNITED STATES;

ANIMALS; DATABASES, FACTUAL; DOG DISEASES; DOGS; EYE NEOPLASMS; FEMALE; HISTIOCYTIC DISORDERS, MALIGNANT; IMMUNOHISTOCHEMISTRY; MALE; WISCONSIN;

CANIS FAMILIARIS;

EID: 34247115563     PISSN: 14635216     EISSN: 14635224     Source Type: Journal    
DOI: 10.1111/j.1463-5224.2007.00534.x     Document Type: Article

References (34)

1. Affolter VK, Moore PF. Canine cutaneous histiocytic diseases. In: Kirk's Current Veterinary Therapy, Vol. XIII. (ed. Bonagura JD) W.B. Saunders, Philadelphia, 2000; 588-591.
2. Affolter VK, Moore PF. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Veterinary Pathology 2002; 39: 74-83.
3. Jacobs RM, Messick JB, Valli VE. Tumors of the hemolymphatic system. In: Tumors in Domestic Animals, 4th edn. (ed. Meuten DJ) Iowa State Press, Ames, 2002; 170-173.
4. Valli VE, Jacobs RM, Parodi AL et al. Solid myeloid proliferations. In: WHO Histological Classification of Hematopoietic Tumors of Domestic Animals, 2nd series, Vol. III. Armed Forces Institute of Pathology, Washington D.C., 2002; 58-61.
5. Gelatt KN. Histiocytoma of the eyelid of a dog. Veterinary Medicine: Small Animal Clinician 1975; 70: 305.
6. Moore PF. Systemic histiocytosis of Bernese Mountain dogs. Veterinary Pathology 1984; 21: 554-563.
7. Scherlie PH Jr, Smedes SL, Feltz T et al. Ocular manifestation of systemic histiocytosis in a dog. Journal of the American Veterinary Medical Association 1992; 201: 1229-1232.
8. Paterson S, Boydell P, Pike R. Systemic histiocytosis in the Bernese mountain dog. Journal of Small Animal Practice 1995; 36: 233-236.
9. Moore PF, Rosin A. Malignant histiocytosis of Bernese Mountain dogs. Veterinary Pathology 1986; 23: 57-62.
10. Wellman ML, Davenport DJ, Morton D et al. Malignant histiocytosis in four dogs. Journal of the American Veterinary Medical Association 1985; 187: 919-921.
11. Rosin A, Moore PF, Dubielzig RR. Malignant histiocytosis in Bernese Mountain dogs. Journal of the American Veterinary Medical Association 1986; 188: 1041-1045.
12. Hayden DW, Waters DJ, Burke BA et al. Disseminated malignant histiocytosis in a Golden Retriever: clinicopathologic, ultrastructural, and immunohistochemical findings. Veterinary Pathology 1993; 30: 256-264.
13. Ramsey IK, McKay JS, Rudorf H et al. Malignant histiocytosis in three Bernese mountain dogs. Veterinary Record 1996; 138: 440-444
14. Moore PF, Schrenzel MD, Affolter VK et al. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses GDI and specific beta 2-integrin molecules. American Journal of Pathology 1996; 148: 1699-1708.
15. Affolter VK, Moore PF. Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells. American Journal of Dermatopathology 2000a; 22: 40-48.
16. Pernick NL, DaSilva M, Gangi MD et al. 'Histiocytic markers' in melanoma. Modern Pathology 1999; 12: 1072-1077.
17. Wick MR. Immunohistologic features of melanocytic neoplasms. In: Diagnostic Immmohistochemistry, 1st edn. (ed. Dabbs DJ) Curchill Livingstone, Pittsburgh, 2002; 147-161.
18. Moore PF, Affolter VK, Vernau W. Immunophenotyping in the dog. In: Kirk's Current Veterinary Therapy, Vol. XIII. (ed. Bonagura JD) W.B. Saunders, Philadelphia, 2000; 505-509.
19. Padgett GA, Madewell BR, Keller ET et al. Inheritance of histiocytosis in Bernese mountain dogs. Journal of Small Animal Practice 1995; 31:327-330.
20. Collins BK, Moore CP. Diseases and surgery of the canine anterior uvea. In: Veterinary Ophthalmology, 2nd edn. (ed. Gelatt KN) Lippincott Williams & Wilkins, Philadelphia, 1999; 755-795.
21. Komaromy AM, Brooks DE, Kallberg ME et al. Hyphema. Part I. Pathophysiologic considerations. Compendium on Continuing Education for the Practicing Veterinarian 1999; 21: 1064-1092.
22. Massa KL, Gilger BC, Miller TL et al. Causes of uveitis in dogs: 102 cases (1989-2000). Veterinary Ophthalmology 2002; 5: 93-98.
23. Dubielzig RR, Grendahl RL, OrcuttJC et al. Metastases. In: Ocular Tumors in Animals and Humans, 1st edn. (ed. Peiffer RL) Iowa State Press, Ames, 2002; 337-378.
24. Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Medical and Pediatric Oncology 1997; 29: 157-237.
25. Moore PF. Utilization of cytoplasmic lysozyme immunoreactivity as a histiocytic marker in canine histiocytic disorders. Veterinary Pathology 1986; 23: 757-762.
26. Helm KF. Immunohistochemistry of skin tumors. In: Diagnostic Immunohistochemistry, 1st edn. (ed. Dabbs DJ) Curchill Livingstone, Pittsburgh, 2002; 313-332.
27. Danilenko DM, Moore PF, Rossitto PV. Canine leukocyte cell adhesion molecules (LeuCAMs): characterization of the CD11/CD18 amily. Tissue Antigens 1992; 40: 13-21.
28. Fernandez NJ, West KH, Jackson ML et al. Immunohistochemical and histochemical stains for differentiating canine cutaneous round cell tumors. Veterinary Pathology 2005; 42: 437-445.
29. Smith SH, Goldschmidt Mil, McManus PM. A comparative review of melanocytic neoplasms. Veterinary Pathology 2002; 39: 651-678.
30. Choi C, Kusewitt DF. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas. Veterinary Pathology 2003; 40: 713-718.
31. Ramos-Vara JA, Beissenherz ME, Miller MA et al. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Veterinary Pathology 2000; 37: 597-608.
32. Koenig A, Wojcieszyn J, Weeks R et al. Expression of S100a, Vimentin, NSE, and Melan A in seven canine melanoma cell lines and twenty-nine retrospective cases of canine melanoma. Veterinary Pathology 2001; 38: 427-435.
33. Taylor CR, Shi SR, Barr NJ et al. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In: Diagnostic Immuno-histochemistry, 1st edn. (ed. Dabbs DJ) Churchill Livingstone, Pittsburgh, 2002; 3-43.
34. Ramos-Vara JA. Technical aspects of immunohistochemistry. Veterinary Pathology 2005; 42: 405-426.